首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1698444

心臟定位市場：2025-2030 年全球預測

Global Cardiac Mapping Market - Forecasts from 2025 to 2030

出版日期: 2025年03月06日 | 出版商:

Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計到 2025 年心臟定位市場價值將達到 1,423,559,000 美元，到 2030 年預計將達到 2,291,392,000 美元，複合年成長率為 9.99%。

心臟定位是電生理學 (EP) 的研究。心臟定位過程有助於識別心臟中不同類型的時間和空間分佈。該系統還有助於準確識別不同部位的異常心律並進行射頻心導管電氣燒灼術治療。全球心血管疾病盛行率的上升是預測期內推動該市場成長的主要因素。同樣，心臟定位設備的技術進步也有望推動市場擴張。成功治療心房顫動的新型有效技術為市場相關人員提供了寶貴的機會，以增強其市場競爭力並加速整體市場成長。

市場趨勢：

全球心血管疾病患者數量增加：心律不整、心臟病和冠狀動脈疾病等心血管疾病的盛行率不斷上升是心臟定位市場的主要驅動力。根據美國疾病管制與預防中心 (CDC) 的數據，2022 年記錄的心血管疾病病例為 702,880 例，凸顯了對先進心臟定位解決方案的需求日益成長。
技術進步：醫療技術的創新提高了心臟定位系統的準確性和效率，從而推動了需求。
改善醫療保健基礎設施和政府政策：改善全球醫療保健基礎設施和支持性政府政策是推動心臟定位系統發展和採用的關鍵因素。
北美市場發展：預計預測期內北美將佔據心臟定位市場的大部分佔有率。這是因為該地區擁有完善的醫療保健行業、優質的醫療服務以及較早採用先進的醫療設備。此外，美國等國家老年人口的成長以及心臟相關問題風險的增加也推動了對心臟定位系統的需求。

報告中介紹的主要企業包括 Biosense Webster, Inc.、Medtronic、Abbott、BIOTRONIK SE &Co KG、Acutus Medical、Boston Scientific Corporation、AMETEK Inc.、Catheter Precision Inc.、Medical Device Business Services, Inc. (Johnson&Johnson)、MicroPort Scientific Corporation.

本報告的主要優點

深刻分析：獲得涵蓋主要地區和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率分析
收益成長和預測分析（包括國家在內的細分市場和地區）
公司概況（策略、產品、財務資訊、主要趨勢等）

Cardiac mapping is the study of electrophysiology or EP. The cardiac mapping process helps in identifying various types of temporal and spatial distribution in the heart. This system also helps in accurately recognizing various sites of abnormal rhythm and delivers radio-frequency catheter ablation therapy. The increasing global prevalence of cardiovascular diseases is the major factor propelling this market's growth during the forecasted timeline. Similarly, technological advancements in cardiac mapping devices are also estimated to propel market expansion. New and effective techniques for the successful treatment of atrial fibrillation are offering market players valuable opportunities to enhance their competitive position and accelerate overall market growth.

Market Trends:

Rising Global Cardiovascular Disease Cases: The increasing prevalence of cardiovascular diseases, such as arrhythmias, heart attacks, and coronary artery disease, is a key driver of the cardiac mapping market. According to the U.S. Centers for Disease Control and Prevention (CDC), there were 702,880 recorded cases of cardiovascular diseases in 2022, highlighting the growing demand for advanced cardiac mapping solutions.
Technological Advancements: Innovations in medical technology are enhancing the accuracy and efficiency of cardiac mapping systems, driving their demand. These advancements are making cardiac mapping more effective and accessible, contributing to market growth.
Improved Healthcare Infrastructure and Government Policies: Global improvements in healthcare infrastructure, along with supportive government policies, are significant factors boosting the development and adoption of cardiac mapping systems.
North America's Market Leadership: North America is expected to hold a substantial share of the cardiac mapping market during the forecast period. This is due to the region's well-established healthcare industry, availability of high-quality medical services, and early adoption of advanced medical devices. Additionally, the growing elderly population and increased risk of heart-related issues in countries like the U.S. are driving demand for cardiac mapping systems.

Some of the major players covered in this report include Biosense Webster, Inc., Medtronic, Abbott, BIOTRONIK SE & Co KG, Acutus Medical, Boston Scientific Corporation, AMETEK Inc., Catheter Precision Inc., Medical Device Business Services, Inc. (Johnson&Johnson), MicroPort Scientific Corporation, Koninklijke Philips N.V, and Kardium Inc. among others.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Global Cardiac Mapping Market is analyzed into the following segments:

By Product

EP Ablation Catheters
EP Laboratory Devices
EP Diagnostic Catheters
Access Devices

By Indication

Atrial Fibrillation
Atrial Flutter
Atrioventricular Nodal Re-entry Tachycardia
Wolff-Parkinson-White Syndrome

By End-User

Hospitals and Clinics
Diagnostic Centers

By Region

North America
Europe
Asia Pacific
South America
Middle East & Africa

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CARDIAC MAPPING MARKET BY PRODUCT

5.1. Introduction
5.2. EP Ablation Catheters
5.3. EP Laboratory Devices
5.4. EP Diagnostic Catheters
5.5. Access Devices

6. GLOBAL CARDIAC MAPPING MARKET BY INDICATION

6.1. Introduction
6.2. Atrial Fibrillation
6.3. Atrial Flutter
6.4. Atrioventricular Nodal Re-entry Tachycardia
6.5. Wolff-Parkinson-White Syndrome

7. GLOBAL CARDIAC MAPPING MARKET BY END-USER

7.1. Introduction
7.2. Hospitals and Clinics
7.3. Diagnostic Centers

8. GLOBAL CARDIAC MAPPING MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Product
- 8.2.2. By Indication
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. USA
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Product
- 8.3.2. By Indication
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Product
- 8.4.2. By Indication
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. United Kingdom
  - 8.4.4.2. Germany
  - 8.4.4.3. France
  - 8.4.4.4. Spain
  - 8.4.4.5. Others
8.5. Middle East and Africa
- 8.5.1. By Product
- 8.5.2. By Indication
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Others
8.6. Asia Pacific
- 8.6.1. By Product
- 8.6.2. By Indication
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. China
  - 8.6.4.2. Japan
  - 8.6.4.3. India
  - 8.6.4.4. South Korea
  - 8.6.4.5. Taiwan
  - 8.6.4.6. Others